STOK
Stoke Therapeutics Inc
24.80$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -2,230.2% | -256.9% | -923.3% | -237.6% | 24.7% | |
| – | – | – | – | 32.5% | 12.5% | 28.1% | 6.0% | 1.0% | |
| – | – | – | – | 548.3% | 184.2% | 287.7% | 75.1% | 17.5% | |
| – | – | – | – | 549.3% | 184.2% | – | – | – | |
| – | – | – | – | 1.5% | 346.8% | -68.7% | -77.0% | 8.9% | |
| – | – | – | – | 40.0% | 31.9% | 18.4% | 0.6% | 0.4% | |
| – | – | – | – | -2,547.5% | -369.9% | 1,206.7% | -294.0% | -101.3% | |
| – | – | – | – | 42.9% | 8.6% | – | – | – | |
| – | – | – | – | 42.8% | 374.1% | 603.7% | 358.6% | 52.8% | |
| – | – | – | – | -4,735.0% | -252.6% | 887.1% | -173.0% | -23.8% | |
| – | – | – | – | -2,270.2% | -288.8% | -941.7% | -238.1% | 24.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.